About: Silexion Therapeutics Corp, a clinical-stage biotechnology company, discovers and develops RNA interference (RNAi) therapies for KRAS-driven cancers. Its products comprise SIL204 second-generation small interfering RNA (siRNA) undergoing phase 2/3 clinical evaluation for pancreatic cancer and silence mutant KRAS oncogene expression. The company was founded in 2008 and is headquartered in Ramat Gan, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.19 (+14.29%)
SLXN NASDAQ Biomotion Sciences Ordinary Shares
Loading watchlist status…
Biomotion Sciences Ordinary Shares share price
SLXN price activity
Last Price
$0.170
Change (24hr)
0.01 USD (3.21%)
Volume
360.81K
Volume (4w avg)
-
Open
$0.17
Day Range
$0.16 - $0.17
Previous Close
$0.17
Last Trade
23 Oct, 2:44 pm GMT+0
Delayed
23 Oct, 2:44 pm GMT+0
SLXN price performance
+11.44%
5D
-45.87%
1M
-99.11%
YTD
-99.49%
1Y
Delayed
23 Oct, 2:44 pm GMT+0
SLXN Market Signals